"A cancer diagnosis can come as a shock, making you feel overwhelmed, scared and helpless. Knowing what to expect can help alleviate some of these feelings. Very few cancers require emergency treatment, so take some time to learn about your diagnosis and treatment options, and ask questions. If youre not already a patient, we invite you to see us for a second opinion."

During the past decade, US Oncology - Willamette Valley Cancer Institute - Eugene conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "US Oncology - Willamette Valley Cancer Institute - Eugene" are "Acute Lymphoid Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Anemia, Refractory, With Excess of Blasts" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Lymphoma, B-Cell" (1 trials). Many other conditions were trialed in "US Oncology - Willamette Valley Cancer Institute - Eugene" in a lesser frequency.

Most popular intervention types in "US Oncology - Willamette Valley Cancer Institute - Eugene" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "brentuximab vedotin" (2 trials) and "rituximab" (1 trials). Other intervention names were less common.

The vast majority of trials in "US Oncology - Willamette Valley Cancer Institute - Eugene" are 4 trials for "All" genders.

Currently, there are NaN active trials in "US Oncology - Willamette Valley Cancer Institute - Eugene". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in US Oncology - Willamette Valley Cancer Institute - Eugene, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in US Oncology - Willamette Valley Cancer Institute - Eugene, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".